Intralesional HPV Vaccine for Condylomata

Status Recruiting

Clinical Trial Summary

This study will investigate whether injecting genital warts with small quantities of the Gardasil 9 vaccine has an effect on the warts.

Clinical Trial Description

This is a prospective, open-label, proof-of-concept research study to assess the effectiveness of intralesional nonavalent in the treatment of patients with genital condylomata. The study will be conducted at Zuckerberg San Francisco General Hospital. The planned intervention is to provide 10 subjects with at least 3 genital condylomata with intralesional nonavalent human papillomavirus vaccine (Gardasil 9) at 0 and 4 weeks. Then, the study subjects will be followed for a further 8 weeks to monitor for change in wart size and wart number. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05087849
Study type	Interventional
Source	University of California, San Francisco
Contact	Ayan Kusari, MD
Phone	628-206-4777
Email	ayan.kusari@ucsf.edu
Status	Recruiting
Phase	Phase 1/Phase 2
Start date	April 15, 2022
Completion date	July 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05329961` - Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old, An Exploratory Immunogenicity Study	Early Phase 1
Completed	`NCT05862844` - Promise Women Project	N/A
Active, not recruiting	`NCT04199078` - Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions.	N/A
Recruiting	`NCT05566106` - Anal Follow-up of Patients With a Gynecological History of High-grade Lesion and More Induced HPV
Not yet recruiting	`NCT06436274` - Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.	Phase 4
Not yet recruiting	`NCT06229353` - Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
Completed	`NCT01757392` - Candin Safety & Efficacy Study for the Treatment of Warts	Phase 2
Active, not recruiting	`NCT04716127` - A Proximity-incentive Strategy for Cervical Cancer Screening	N/A
Recruiting	`NCT05210348` - Clinical Evaluation of Detection of High Risk HPV in Urine
Recruiting	`NCT05835947` - Anal Cancer Risk In Women
Not yet recruiting	`NCT03947775` - HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL	Phase 2
Terminated	`NCT03404310` - Zinc Sulfate for Human Papillomavirus (HPV)	N/A
Recruiting	`NCT03302858` - A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand	Phase 2
Completed	`NCT03082950` - HPV Infections, Cancer of the Vulva and Therapeutical Success
Active, not recruiting	`NCT04950101` - Prevalence of Anal High-risk Human Papilloma Virus Infection and Abnormal Anal Cytology in Men Who Have Sex With Men Using Pre Exposure Prophylaxis	N/A
Recruiting	`NCT05146895` - A Cohort Study of Hyperthermia and Imiquimod for the Treatment of Flat Warts	N/A
Completed	`NCT04002154` - Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPV	N/A
Recruiting	`NCT04232917` - Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.	Phase 4
Active, not recruiting	`NCT03729518` - TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck	N/A
Recruiting	`NCT05640700` - Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia